Showing results (121-130 of 373) with videos related to
Sort By:
Pageof 38
Cancer Discovery|April 3, 2021
Tracking Cancer Evolution through the Disease CourseChris Bailey, James R M Black, James L Reading, et al.G3 (Bethesda, Md.)|September 18, 2014
The genome of the chicken DT40 bursal lymphoma cell lineJános Molnár, Ádám Póti, Orsolya Pipek, et al.Nature Reviews. Clinical Oncology|May 8, 2013
Taxane benefit in breast cancer--a role for grade and chromosomal stabilityRoger P A'Hern, Mariam Jamal-Hanjani, A Marcell Szász, et al.Nature Reviews. Disease Primers|March 10, 2017
Renal cell carcinomaJames J Hsieh, Mark P Purdue, Sabina Signoretti, et al.Cancer Research|April 8, 2014
Predictive performance of microarray gene signatures: impact of tumor heterogeneity and multiple mechanisms of drug resistanceCharlotte K Y Ng, Britta Weigelt, Roger A'Hern, et al.Trends in Cancer|June 5, 2024
Implementing circulating tumor DNA as a prognostic biomarker in resectable non-small cell lung cancerChris Abbosh, Darren Hodgson, Gary J Doherty, et al.Acta Oncologica (Stockholm, Sweden)|March 21, 2006
Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumabThomas Yau, Charles Swanton, Sue Chua, et al.Breast Cancer Research and Treatment|March 19, 2013
A 3-gene proliferation score (TOP-FOX-67) can re-classify histological grade-2, ER-positive breast cancers into low- and high-risk prognostic categoriesBorbala Szekely, Takayuki Iwamoto, A Marcell Szasz, et al.Nature Communications|September 26, 2022
RAS oncogenic activity predicts response to chemotherapy and outcome in lung adenocarcinomaPhilip East, Gavin P Kelly, Dhruva Biswas, et al.Cell|March 29, 2024
Cancer biomarkers: Emerging trends and clinical implications for personalized treatmentAntonio Passaro, Maise Al Bakir, Emily G Hamilton, et al.Pageof 38